Significance of Analyzing Gene Mutations in Prostate Cancer

Joshua Armenia, PhD
Published: Monday, Apr 24, 2017



Joshua Armenia, PhD, Memorial Sloan Kettering Cancer Center, discusses the significance of analyzing mutated genes in prostate cancer.

The biggest cohort of patients with prostate cancer has not led to the discovery of biomarkers for advanced disease. Primary metastatic tumors need to be studied in more detail to determine the evolution of this disease.

It would also be interesting to identify markers of progression for patients with advanced disease within primary tumors by comparing the genomic alterations across lesions.



Joshua Armenia, PhD, Memorial Sloan Kettering Cancer Center, discusses the significance of analyzing mutated genes in prostate cancer.

The biggest cohort of patients with prostate cancer has not led to the discovery of biomarkers for advanced disease. Primary metastatic tumors need to be studied in more detail to determine the evolution of this disease.

It would also be interesting to identify markers of progression for patients with advanced disease within primary tumors by comparing the genomic alterations across lesions.




View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Clinical Vignette Series: 34th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®Feb 28, 20182.0
Community Practice Connections™: Personalized Sequencing in Castration-Resistant Prostate Cancer: Bridging the Latest Evidence to the Bedside in Clinical ManagementAug 25, 20181.5
Publication Bottom Border
Border Publication
x